At MediciGlobal 100% of our award-winning VIP® retention programmes are successful in keeping children, teens and adults in studies until completion. That’s because we customise each programme to the study’s design and its patient population. So patients stay engaged – and Sponsors worldwide get the statistically powered data necessary for drug approvals. Plus, we minimize lost-to-follow-up to ensure that nearly all patient data is accounted for.